Literature DB >> 10672177

Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress.

S Krieger1, W Schwarz, M R Ariyanayagam, A H Fairlamb, R L Krauth-Siegel, C Clayton.   

Abstract

In Kinetoplastida, trypanothione and trypanothione reductase (TRYR) provide an intracellular reducing environment, substituting for the glutathione-glutathione reductase system found in most other organisms. To investigate the physiological role of TRYR in Trypanosoma brucei, we generated cells containing just one trypanothione reductase gene, TRYR, which was under the control of a tetracycline-inducible promoter. This enabled us to regulate TRYR activity in the cells from less than 1% to 400% of wild-type levels by adjusting the concentration of added tetracycline. In normal growth medium (which contains reducing agents), trypanosomes containing less than 10% of wild-type enzyme activity were unable to grow, although the levels of reduced trypanothione and total thiols remained constant. In media lacking reducing agents, hypersensitivity towards hydrogen peroxide (EC50 = 3.5 microM) was observed compared with the wild type (EC50 = 223 microM). The depletion of TRYR had no effect on susceptibility to melarsen oxide. The infectivity and virulence of the parasites in mice was dependent upon tetracycline-regulated TRYR activity: if the trypanosomes were injected into mice in the absence of tetracycline, no infection was detectable; and when tetracycline was withdrawn from previously infected animals, the parasitaemia was suppressed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10672177     DOI: 10.1046/j.1365-2958.2000.01721.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  90 in total

1.  Roles of triosephosphate isomerase and aerobic metabolism in Trypanosoma brucei.

Authors:  S Helfert; A M Estévez; B Bakker; P Michels; C Clayton
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

Review 2.  Parasite-specific trypanothione reductase as a drug target molecule.

Authors:  R Luise Krauth-Siegel; Oliver Inhoff
Journal:  Parasitol Res       Date:  2003-04-23       Impact factor: 2.289

Review 3.  Information-based methods in the development of antiparasitic drugs.

Authors:  Kristina Wolf; Matthias Dormeyer
Journal:  Parasitol Res       Date:  2002-12-04       Impact factor: 2.289

4.  Transgenic biosynthesis of trypanothione protects Escherichia coli from radiation-induced toxicity.

Authors:  Matthew P Fitzgerald; Joshua M Madsen; Mitchell C Coleman; Melissa L T Teoh; Scott G Westphal; Douglas R Spitz; Rafael Radi; Frederick E Domann
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

5.  Reactive oxygen species-mediated immunity against Leishmania mexicana and Serratia marcescens in the sand phlebotomine fly Lutzomyia longipalpis.

Authors:  Hector Diaz-Albiter; Mauricio R V Sant'Anna; Fernando A Genta; Rod J Dillon
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

6.  High throughput screening against the peroxidase cascade of African trypanosomes identifies antiparasitic compounds that inactivate tryparedoxin.

Authors:  Florian Fueller; Britta Jehle; Kerstin Putzker; Joe D Lewis; R Luise Krauth-Siegel
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

Review 7.  Target assessment for antiparasitic drug discovery.

Authors:  Julie A Frearson; Paul G Wyatt; Ian H Gilbert; Alan H Fairlamb
Journal:  Trends Parasitol       Date:  2007-10-24

8.  Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity.

Authors:  Georgina A Holloway; William N Charman; Alan H Fairlamb; Reto Brun; Marcel Kaiser; Edmund Kostewicz; Patrizia M Novello; John P Parisot; John Richardson; Ian P Street; Keith G Watson; Jonathan B Baell
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

9.  In silico structural characterization of protein targets for drug development against Trypanosoma cruzi.

Authors:  Carlyle Ribeiro Lima; Nicolas Carels; Ana Carolina Ramos Guimaraes; Pierre Tufféry; Philippe Derreumaux
Journal:  J Mol Model       Date:  2016-09-24       Impact factor: 1.810

10.  ATP-dependent ligases in trypanothione biosynthesis--kinetics of catalysis and inhibition by phosphinic acid pseudopeptides.

Authors:  Sandra L Oza; Shoujun Chen; Susan Wyllie; James K Coward; Alan H Fairlamb
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.